User:Tkadm30/Notebook/THC: Difference between revisions
From OpenWetWare
< User:Tkadm30 | Notebook
(New page: Sweet Marijane, Before the dawn of ages you have cured the afflicted from mental oppression, We have learned to cultivate you even you were repressed from repressors of the truth, We h...) |
|||
(23 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
__TOC__ | |||
===Synopsis=== | |||
* Tetrahydrocannabinol (THC) is the main psychoactive constituent of Cannabis sativa L (Marijuana) plant. | |||
* Other Marijuana compounds includes Cannabichromene (CBC), Cannabidiol (CBD), Cannabinol (CBN), and Cannabigerol (CBG). | |||
* Cannabis-derived cannabinoids are known as phytocannabinoids. | |||
* THC stimulate anandamide biosynthesis by binding to the CB1 receptor, thus producing a antidepressant and neuroprotective effect. [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2866040/ PMID] [https://www.ncbi.nlm.nih.gov/pubmed/7702643 PMID] | |||
===Anticholinergic properties of THC=== | |||
* THC inhibit anticholinesterase (AChE) induced beta-amyloid aggregation in Alzheimer's disease: [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2562334/ PMID] | |||
* THC as antiglutamatergic therapy for AChE induced neurotoxicity: [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2891218/ PMID] [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3366364/ PMID] [https://www.ncbi.nlm.nih.gov/pubmed/18680758 PMID] | |||
* Unlike THC, caffeine is a noncompetitive reversible inhibitor of AChE | |||
===Proneurogenic effect of THC on neurogenesis=== | |||
* Regulation of stress-induced neuroinflammation in the hippocampus. | |||
* Hippocampal neurogenesis is enhanced. [https://www.ncbi.nlm.nih.gov/pubmed/16224541/ PMID] [https://www.ncbi.nlm.nih.gov/pubmed/17828287 PMID] | |||
* CB1 activation promote neuronal cell proliferation, differentiation, maturation, and neurite growth. [https://www.ncbi.nlm.nih.gov/pubmed/23704915 PMID] | |||
===Experimental=== | |||
* Synaptogenic effect of Δ9-THC/DHEA ligands promote hippocampal development. | |||
* Δ9-THC/DHEA ligands (synaptamide) affect neural stem/progenitor cells (NS/PC) proliferation in the hippocampus. | |||
===References=== | |||
# https://en.wikipedia.org/wiki/Cannabinoid | |||
===See also=== | |||
* [[User:Etienne_Robillard/Notebook/TRPV1|TRPV1 Notebook]] | |||
[[User: |
Revision as of 05:05, 20 August 2015
Synopsis
- Tetrahydrocannabinol (THC) is the main psychoactive constituent of Cannabis sativa L (Marijuana) plant.
- Other Marijuana compounds includes Cannabichromene (CBC), Cannabidiol (CBD), Cannabinol (CBN), and Cannabigerol (CBG).
- Cannabis-derived cannabinoids are known as phytocannabinoids.
- THC stimulate anandamide biosynthesis by binding to the CB1 receptor, thus producing a antidepressant and neuroprotective effect. PMID PMID
Anticholinergic properties of THC
- THC inhibit anticholinesterase (AChE) induced beta-amyloid aggregation in Alzheimer's disease: PMID
- THC as antiglutamatergic therapy for AChE induced neurotoxicity: PMID PMID PMID
- Unlike THC, caffeine is a noncompetitive reversible inhibitor of AChE
Proneurogenic effect of THC on neurogenesis
- Regulation of stress-induced neuroinflammation in the hippocampus.
- Hippocampal neurogenesis is enhanced. PMID PMID
- CB1 activation promote neuronal cell proliferation, differentiation, maturation, and neurite growth. PMID
Experimental
- Synaptogenic effect of Δ9-THC/DHEA ligands promote hippocampal development.
- Δ9-THC/DHEA ligands (synaptamide) affect neural stem/progenitor cells (NS/PC) proliferation in the hippocampus.